StockpollyBeta
Get App
Popularity #2,160
CRVS · NASDAQ · Biotechnology

Corvus Pharmaceuticals (CRVS)

Develops immune-disease and cancer therapies centered on soquelitinib.

$12.51
vs last close−0.93 (−6.92%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions≈ 83.11%69.91M shares
188 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders7.91%6.66M shares
5 holders · as of Jun 15, 2026
Other≈ 8.98%7.55M shares
remainder

84.12M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

13F · 13D/G · Form 4

HolderStakeSharesDate
Orbimed Advisors LLCInstitution
8.52%7.17Mas of Jun 30, 2026
BlackRock, Inc.Institution
8.49%7.14Mas of Jun 30, 2026
Sirenia Capital Management LPInstitution
8.12%6.83Mfiled May 15, 2026
Richard A. Md Miller1Insiderdirector, officer: President and CEO
7.24%6.09Mfiled May 20, 2026
State Street CorpInstitution
5.32%4.47Mas of Jun 30, 2026
Price T Rowe Associates Inc /MD/Institution
4.50%3.79Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
3.91%3.29Mas of Jun 30, 2026
Adams Street Partners LLCInstitution
3.89%3.28Mas of Jun 30, 2026
Vivo Capital, LLCInstitution
3.34%2.81Mas of Jun 30, 2026
Wellington Management Group LLPInstitution
3.25%2.73Mas of Jun 30, 2026
Perceptive Advisors LLCInstitution
3.17%2.67Mas of Jun 30, 2026
Deep Track Capital, LPInstitution
2.96%2.49Mas of Jun 30, 2026
Braidwell LPInstitution
2.53%2.13Mas of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.20%1.85Mas of Jun 30, 2026
Foresite Capital Management Vi LLCInstitution
2.18%1.83Mas of Jun 30, 2026
Goldman Sachs Group IncInstitution
1.87%1.58Mas of Jun 30, 2026
Hood River Capital Management LLCInstitution
1.87%1.57Mas of Jun 30, 2026
Morgan StanleyInstitution
1.60%1.34Mas of Jun 30, 2026
Boxer Capital Management, LLCInstitution
1.31%1.10Mas of Jun 30, 2026
Catalio Capital Management, LPInstitution
1.28%1.08Mas of Jun 30, 2026
Millennium Management LLCInstitution
1.25%1.05Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
0.97%814,750as of Jun 30, 2026
Two Sigma Investments, LPInstitution
0.93%785,208as of Jun 30, 2026
Bank of America Corp /DE/Institution
0.90%757,798as of Jun 30, 2026
Adage Capital Partners GP, L.L.C.Institution
0.89%750,000as of Jun 30, 2026
  1. Richard A. Md Miller's transaction reports restate only vehicles that traded; the 2026 ownership statement (6.09M) plus the 6.9K net shares acquired since is used instead.

13F, as of Jun 30, 2026

188 holders · 69.91M shares · 42 new positions · 113 increased · 41 reduced · 30 closed

HolderShares% outstandingChg q/qFiled
Orbimed Advisors LLC7.17M8.52%0Aug 14, 2026
BlackRock, Inc.7.14M8.49%+978.4KAug 7, 2026
State Street Corp4.47M5.32%+908.1KAug 7, 2026
Price T Rowe Associates Inc /MD/3.79M4.50%+871.8KAug 14, 2026
Vanguard Capital Management LLC3.29M3.91%+58.2KAug 13, 2026
Adams Street Partners LLC3.28M3.89%0Aug 14, 2026
Vivo Capital, LLC2.81M3.34%0Aug 14, 2026
Wellington Management Group LLP2.73M3.25%+413.1KAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Orbimed Advisors LLCincl. Orbimed Capital GP V LLC10.30%8.61M13DJan 27, 2026
Richard A. Miller7.80%6.09M13GFeb 13, 2026
Sirenia Capital Management LP7.50%6.83M13GMay 15, 2026
BlackRock, Inc.6.40%5.39M13GApr 27, 2026
State Street Corporation5.30%4.47M13GAug 7, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jun 11, 2026
David Scott Mooredirector
Purchase21,700$11.5321,700
May 18, 2026
Richard A. Md Millerdirector, officer: President and CEO
Purchase · 2 lots6,932$12.041,195,035

House and Senate disclosures

Not reported.